Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot# XL999-203: A Phase 2 Study of XL999 Administered Intravenously to Subjects with Relapsed/Refractory Multiple Myeloma
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
8/23/06
→
8/23/09
Funding
National Cancer Institute
(R01 CA125077)
View all
View less